Coverage
-
March 15, 2019
Pfizer Inc. and its Hospira Inc. unit have beat a False Claims Act suit accusing them of silently fixing defects with infusion pumps without telling customers or the U.S. Food and Drug Administration, with an Illinois federal judge saying the whistleblower didn't specifically allege any Medicare fraud.
2 other articles on this case.
View all »